Cell & Gene Development & Clinical Technology & Manufacturing

Manufacturing Viral Vectors for the Next Phase of CGT

As the sector matures, scalable vector production and robust analytical control are becoming essential to clinical and commercial success

04/30/2026 7 min read

Development & Clinical Cell & Gene Interviews

October 1, 2026

3 min read

Cellares Co-Founder and CEO discusses why the future of cell therapy depends on rethinking how therapies are made

Cell & Gene

September 30, 2026

10 min read

How direct T-cell reprogramming could simplify CAR-T manufacturing, expand patient access, and extend cellular immunotherapy to new indications

Development & Clinical Future of Pharma

September 29, 2026

5 min read

Coordinated development and practical testing pathways can help ensure eligible patients are identified from the point of approval

Cell & Gene Industry News Development & Clinical

September 28, 2026

3 min read

Phase I study will test whether a targeted lentiviral vector can generate BCMA-directed CAR T cells inside patients with multiple myeloma